ENVBEnveric Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Enveric Biosciences, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENVB본 종목 | $7M#8 | — | 0.8x#4 | 0.2x#1 | -7.2%#6 | 26.0%#11 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#3 | -86.4%#10 | — |
| XCUR | $9M#1 | — | 9.0x#12 | — | -100.0%#9 | 49.0%#5 | — | -506.2%#12 | — | — | -64.6%#4 | — |
| TRAW | $8M#2 | — | 0.7x#3 | 2.9x#6 | 1134.5%#1 | 105.5%#1 | -640.7%#6 | 79.2%#2 | — | — | -75.7%#8 | — |
| SNGX | $8M#3 | — | 1.2x#8 | 65.8x#8 | -85.8%#8 | -33.7%#12 | -9923.2%#8 | -167.0%#7 | — | 5#1 | -87.0%#11 | — |
| IMNN | $8M#4 | — | — | — | — | — | — | — | — | — | -74.4%#7 | — |
| ACXP | $7M#5 | — | 0.9x#6 | — | — | 43.5%#8 | — | -97.7%#6 | — | — | -66.6%#5 | — |
| BOLT | $7M#6 | — | 0.6x#1 | 0.9x#3 | 0.1%#5 | 47.1%#6 | -469.3%#5 | -264.1%#10 | — | — | -28.8%#1 | — |
| SYBX | $7M#7 | — | 0.6x#2 | — | -100.0%#9 | 95.7%#2 | — | -8.4%#4 | — | — | -63.8%#3 | — |
| ERNA | $6M#9 | 0.1x#1 | 2.0x#10 | 11.0x#7 | 755.9%#2 | 68.4%#4 | -1601.2%#7 | -440.1%#11 | -1016.2%#4 | — | -87.4%#12 | — |
| PULM | $5M#11 | — | 2.0x#11 | 0.7x#2 | 7.0%#4 | 46.0%#7 | -66.2%#2 | -201.9%#8 | -235.7%#2 | — | -71.6%#6 | — |
| XBIO | $5M#12 | — | 0.9x#5 | 1.7x#5 | 19.0%#3 | 32.3%#10 | -95.2%#3 | -44.1%#5 | -1516.8%#5 | 4#2 | -35.3%#2 | — |
| LABT | $5M#13 | — | 1.2x#7 | — | — | — | — | 0.0%#3 | — | — | — | — |
| PRPH | $6M#10 | — | — | 1.3x#4 | -35.8%#7 | 72.4%#3 | -415.4%#4 | — | -804.6%#3 | — | -91.5%#13 | — |
| DRMA | $5M#14 | — | 1.3x#9 | — | — | 38.5%#9 | — | -216.7%#9 | — | — | -79.5%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice